Evaluation of the MD Anderson tumor score for diffuse large B‐cell lymphoma in the rituximab era.

MLA

Gutierrez, Antonio, et al. “Evaluation of the MD Anderson Tumor Score for Diffuse Large B‐cell Lymphoma in the Rituximab Era.” European Journal of Haematology, vol. 104, no. 5, May 2020, pp. 400–08. EBSCOhost, https://doi.org/10.1111/ejh.13364.

APA

Gutierrez, A., Bento, L., Diaz, L. A., Barranco, G., Garcia, R. M., Lopez, G. A., Dlouhy, I., Rovira, J., Rodriguez, M., Sanchez Pina, J. M., Baile, M., Martín, A., Novelli, S., Sancho, J., García, O., Salar, A., Bastos, O. M., Rodriguez, S. M. J., Fernandez, R., & Cruz, F. (2020). Evaluation of the MD Anderson tumor score for diffuse large B‐cell lymphoma in the rituximab era. European Journal of Haematology, 104(5), 400–408. https://doi.org/10.1111/ejh.13364

Chicago

Gutierrez, Antonio, Leyre Bento, Lopez, Antonio Diaz, Gilberto Barranco, Recio, Marta Garcia, Guillermo, Armando Lopez, Ivan Dlouhy, et al. 2020. “Evaluation of the MD Anderson Tumor Score for Diffuse Large B‐cell Lymphoma in the Rituximab Era.” European Journal of Haematology 104 (5): 400–408. doi:10.1111/ejh.13364.